CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

This study has been completed.

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Fred Hutchinson Cancer Research Center

ClinicalTrials.gov Identifier:

NCT01475058

First received: November 10, 2011

Last updated: August 4, 2015

Last verified: August 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2014 (Final data collection date for primary outcome measure)